Old Web
English
Sign In
Acemap
>
authorDetail
>
Kathleen N. Moore
Kathleen N. Moore
University of Oklahoma Medical Center
Medicine
Pathology
Oncology
Internal medicine
MIRVETUXIMAB SORAVTANSINE
4
Papers
11
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
MIRASOL (GOG 3045/ENGOT OV-55): A randomized, open-label, phase III study of mirvetuximab soravtansine versus investigator’s choice of chemotherapy in advanced high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancers with high folate-alpha (FRα) expression.
2020
Journal of Clinical Oncology
Kathleen N. Moore
Toon Van Gorp
Jiuzhou Wang
Brooke Esteves
Patrick A. Zweidler-McKay
Show All
Source
Cite
Save
Citations (3)
DUO-E/GOG-3041/ENGOT-EN10: a randomized phase III trial of first-line carboplatin (carb) and paclitaxel (pac) in combination with durvalumab (durva), followed by maintenance durva with or without olaparib (ola), in patients (pts) with newly diagnosed (nd) advanced or recurrent endometrial cancer (EC).
2020
Journal of Clinical Oncology
Shannon Neville Westin
Kathleen N. Moore
Els Van Nieuwenhuysen
Amit M. Oza
Linda Mileshkin
Aikou Okamoto
Akiko Suzuki
Kassondra Meyer
Laura Barker
Joon Rhee
Ignace Vergote
Show All
Source
Cite
Save
Citations (3)
Clinical trial in progress: Pivotal study of VB-111 combined with paclitaxel versus paclitaxel for treatment of platinum-resistant ovarian cancer (OVAL, VB-111-701/GOG-3018).
2020
Journal of Clinical Oncology
Rebecca C. Arend
Bradley J. Monk
Robert A. Burger
Thomas J. Herzog
Jonathan A. Ledermann
Kathleen N. Moore
Angeles Alvarez Secord
Roni Shapira
Krishnansu S. Tewari
Marilyn Huang
Amnon Amit
Tamar Rachmilewitz Minei
Dror Harats
Richard T. Penson
Show All
Source
Cite
Save
Citations (1)
Mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients (pts) with platinum-agnostic ovarian cancer.
2020
Journal of Clinical Oncology
Lucy Gilbert
Ana Oaknin
Ursula A. Matulonis
Gina Mantia-Smaldone
Peter Lim
Cesar M. Castro
Diane Provencher
Sanaz Memarzadeh
Jiuzhou Wang
Brooke Esteves
Patrick A. Zweidler-McKay
Kathleen N. Moore
David M. OMalley
Show All
Source
Cite
Save
Citations (4)
1